|
Vascular Surgery
Citations 1-10 of 29 total displayed.
|
Most recent content
(16 Apr 2008):
|
- Original Contributions
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial
- Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Leonardo Bolognese; Corrado Vassanelli; Salvatore Colangelo; Nicoletta de Cesare; Alfredo E. Rodriguez; Maurizio Ferrario; Raul Moreno; Tommaso Piva; Imad Sheiban; Giampaolo Pasquetto; Francesco Prati; Marco S. Nazzaro; Giovanni Parrinello; Roberto Ferrari; for the Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators
JAMA 2008; 299: 1788-1799.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Apr 1998):
|
- Preliminary Communications
Atherosclerotic Plaque Composition and Occurrence of Restenosis After Carotid Endarterectomy
- Willem E. Hellings; Frans L. Moll; Jean-Paul P. M. De Vries; Rob G. A. Ackerstaff; Kees A. Seldenrijk; Rosemarie Met; Evelyn Velema; Wouter J. M. Derksen; Dominique P. V. De Kleijn; Gerard Pasterkamp
JAMA 2008; 299: 547-554.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
Carotid Artery Surgery Guidelines Updated: New Data Also Support Stents in High-Risk Cases
- Mike Mitka
JAMA 2005; 294: 2955-2956.
[Extract]
[Full text]
[PDF]
- Letters
Drug-Eluting Stents and In-Stent Restenosis—Reply
- Adnan Kastrati; Albert Schömig
JAMA 2005; 293: 1855-a-1856-a.
[Extract]
[Full text]
[PDF]
- Letters
Drug-Eluting Stents and In-Stent Restenosis
- Fernando Alfonso
JAMA 2005; 293: 1855.
[Extract]
[Full text]
[PDF]
- Reviews
Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction: A Meta-analysis of Randomized Trials
- Giuseppe De Luca; Harry Suryapranata; Gregg W. Stone; David Antoniucci; James E. Tcheng; Franz-Josef Neumann; Frans Van de Werf; Elliott M. Antman; Eric J. Topol
JAMA 2005; 293: 1759-1765.
[Abstract]
[Full text]
[PDF]
- Clinical Review
Diabetes and Coronary Revascularization
- James D. Flaherty; Charles J. Davidson
JAMA 2005; 293: 1501-1508.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis: A Randomized Controlled Trial
- Adnan Kastrati; Julinda Mehilli; Nicolas von Beckerath; Alban Dibra; Jörg Hausleiter; Jürgen Pache; Helmut Schühlen; Claus Schmitt; Josef Dirschinger; Albert Schömig; for the ISAR-DESIRE Study Investigators
JAMA 2005; 293: 165-171.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Regionalization of Percutaneous Transluminal Coronary Angioplasty and Implications for Patient Travel Distance
- Susan M. Kansagra; Lesley H. Curtis; Kevin A. Schulman
JAMA 2004; 292: 1717-1723.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial
- A. Michael Lincoff; John A. Bittl; Robert A. Harrington; Frederick Feit; Neal S. Kleiman; J. Daniel Jackman; Ian J. Sarembock; David J. Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A. Cohen; Amadeo Betriu; Walter Desmet; Dean J. Kereiakes; Wolfgang Rutsch; Robert G. Wilcox; Pim J. de Feyter; Alec Vahanian; Eric J. Topol; for the REPLACE-2 Investigators
JAMA 2003; 289: 853-863.
[Abstract]
[Full text]
[PDF]
[ Corrected PDF ]
|
|
